Chu-Kuang Chou
Gastroenterology — Chia-Yi Christian Hospital, Taiwan
Chu-Kuang Chou
LeadR Profile
Gastroenterology
Subspecialties: Medical Imaging - Surgery - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 100
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Next-generation microneedle patches for transdermal therapeutics and diagnostics. pharmaceutical preparations, therapeutics, microneedle drug delivery | Discov Nano | 2026 | 0 |
| Impact of Baseline Synchronous Adenoma Burden on the Risk of Metachronous Advanced Neoplasia. gastroenterology, incidence, neoplasms, adenoma, colonoscopy | Am J Gastroenterol | 2026 | 0 |
| Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study. therapeutics, asthma | J Asthma Allergy | 2026 | 0 |
| Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists. diabetes mellitus, depression, glucagon-like peptide 1, glucagon-like peptide-1 receptor, cohort studies, comparative effectiveness research, depressive disorder, obesity, incretins, therapeutics, suicidal ideation, diabetes mellitus, type 2, semaglutide | Diabetes Obes Metab | 2026 | 1 |
| Integrative Transcriptomic and Proteomic Profiling Identifies S100P as a Potential Functional Biomarker for Sessile Serrated Lesions. cells, up-regulation, genes, gastroenterology, neoplasms, biomarkers, adenoma, mucous membrane, wounds and injuries, membranes | Dig Dis Sci | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Phase 2 Study to Evaluate MORF 057 in Adults With Moderately to Severely Active Crohn s Disease NCT06226883 — integrins, safety, crohn disease, inflammatory bowel diseases, small molecules | Phase 2 | Recruiting | 2024 |
| Study of ADI PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma NCT05317819 — carcinoma, hepatocellular, arginine, multiple chronic conditions, genotype, therapeutics, carcinoma | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map